<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.PatentFamilySummaryOutputs xmlns:ns2="local"><PatentFamilySummaryOutput id="548237"><Title>Use of inhibitors of compounds involved in the jun kinase (jnk) biochemical cellular pathway for the treatment or diagnosis of liposarcomas</Title><Assignee>Institut Curie; Universite Pierre Et Marie Curie (Paris Vi); Institut National De La Sante Et De La Recherche Medicale Inserm</Assignee><Familymembers>WO-2004026407</Familymembers><PatentNumber>WO-2004026407</PatentNumber><Indication>Liposarcoma</Indication><Action>KCNK potassium channel-3 inhibitor</Action></PatentFamilySummaryOutput></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.PatentFamilySummaryOutputs>